Information:
Fel:
ID
13873
Beskrivning
Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01313273
Länk
https://clinicaltrials.gov/show/NCT01313273
Nyckelord
Versioner (1)
- 2016-03-13 2016-03-13 -
Uppladdad den
13 mars 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Prostate Cancer NCT01313273
Eligibility Prostate Cancer NCT01313273
- StudyEvent: Eligibility
Similar models
Eligibility Prostate Cancer NCT01313273
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
prostate cancer
Item
histologically proven diagnosis of prostate cancer
boolean
C0600139 (UMLS CUI [1])
orchiectomy; luteinizing hormone releasing hormone agonists
Item
evidence of psa progression despite castrate levels of testosterone (<50 ng/dl) following orchiectomy or during therapy with luteinizing hormone releasing hormone agonists (lhrh-a)
boolean
C0029189 (UMLS CUI [1])
C1518041 (UMLS CUI [2])
C1518041 (UMLS CUI [2])
metastatic disease
Item
patients with non-metastatic or stable metastatic disease
boolean
C0027627 (UMLS CUI [1])
chromogranin; Enzyme-Linked Immunosorbent Assay; Immunoradiometric Assays
Item
chromogranin a elevation above normal range (confirmed by a second evaluation at least 1 week later) [cut off levels will be > 20 u/l for enzyme linked immunosorbent (elisa) assay and > 100 ng/ml for immunoradiometric (irma) assay]
boolean
C0008586 (UMLS CUI [1])
C0014441 (UMLS CUI [2])
C0021073 (UMLS CUI [3])
C0014441 (UMLS CUI [2])
C0021073 (UMLS CUI [3])
chemotherapy docetaxel
Item
patients who according to the investigator opinion are candidates to be treated immediately with chemotherapy (e.g. docetaxel)
boolean
C0392920 (UMLS CUI [1,1])
C0246415 (UMLS CUI [1,2])
C0246415 (UMLS CUI [1,2])
antiandrogen therapy
Item
first line treatment with antiandrogen in monotherapy
boolean
C0279492 (UMLS CUI [1])
metastasis
Item
visceral metastasis
boolean
C0027627 (UMLS CUI [1])
concomitant treatment somatostatin analogue
Item
previous or concomitant treatment with a somatostatin analogue
boolean
C1707479 (UMLS CUI [1,1])
C0732165 (UMLS CUI [1,2])
C0732165 (UMLS CUI [1,2])